TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION

Compare TIMOLOL MALEATE (Timolol Maleate) and TRAVOPROST OPHTHALMIC SOLUTION (Travoprost Ophthalmic Solution) — clinical data, side effects, and patient experiences.

TIMOLOL MALEATE

Timolol Maleate · Glaucoma Agent

How it works

Other agent

Approved for

benzalkonium chloride

or when use of a preservative-free topical medication is advisable.

OphthalmicTablet

TRAVOPROST OPHTHALMIC SOLUTION

Travoprost Ophthalmic Solution · Glaucoma Agent

How it works

12.1 Mechanism of Action Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce IOP by increasing uveoscleral outflo...

Approved for

See full prescribing information

OphthalmicTablet

Quick Comparison

TIMOLOL MALEATETRAVOPROST OPHTHALMIC SOLUTION

Drug Class

Glaucoma Agent

Route

Ophthalmic

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TIMOLOL MALEATE

Drug Not Working

1-10%

Fatigue

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Headache

0.1-1%

Nausea

0.1-1%

TRAVOPROST OPHTHALMIC SOLUTION

Drug Not Working

1-10%

Fatigue

0.1-1%

Blurred Vision

0.1-1%

Dizziness

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

TIMOLOL MALEATE

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically
For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS )
, chronic bronchitis, emphysema) of mild or moderate severity, bronchospastic disease, or a history of bronchospastic disease (other than bronchial asthma or a history of bronchial asthma, in which Timolol Maleate Ophthalmic Solution in OCUDOSE is contraindicated [see CONTRAINDICATIONS ]) should, in general, not receive beta-blockers, including Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE
This may augment the risk of general anesthesia in surgical procedures

TRAVOPROST OPHTHALMIC SOLUTION

5 WARNINGS AND PRECAUTIONS • Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid), and eyelashes can occur
004% should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Clinical Trial Data

No head-to-head clinical studies found for TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION.

TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION: What You Should Know

Key Differences

Both TIMOLOL MALEATE and TRAVOPROST OPHTHALMIC SOLUTION belong to the Glaucoma Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

TIMOLOL MALEATE carries 4 FDA warnings. TRAVOPROST OPHTHALMIC SOLUTION carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DORZOLAMIDE HYDROCHLORIDE vs TRAVOPROST OPHTHALMIC SOLUTION→DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION vs TRAVOPROST OPHTHALMIC SOLUTION→LATANOPROST OPHTHALMIC SOLUTION vs TRAVOPROST OPHTHALMIC SOLUTION→TRAVOPROST vs TRAVOPROST OPHTHALMIC SOLUTION→BRIMONIDINE TARTRATE vs TRAVOPROST OPHTHALMIC SOLUTION→DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION→

Loading comparison data...

TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION

Compare TIMOLOL MALEATE (Timolol Maleate) and TRAVOPROST OPHTHALMIC SOLUTION (Travoprost Ophthalmic Solution) — clinical data, side effects, and patient experiences.

TIMOLOL MALEATE

Timolol Maleate · Glaucoma Agent

How it works

Other agent

Approved for

benzalkonium chloride

or when use of a preservative-free topical medication is advisable.

OphthalmicTablet

TRAVOPROST OPHTHALMIC SOLUTION

Travoprost Ophthalmic Solution · Glaucoma Agent

How it works

12.1 Mechanism of Action Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce IOP by increasing uveoscleral outflo...

Approved for

See full prescribing information

OphthalmicTablet

Quick Comparison

TIMOLOL MALEATETRAVOPROST OPHTHALMIC SOLUTION

Drug Class

Glaucoma Agent

Route

Ophthalmic

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TIMOLOL MALEATE

Drug Not Working

1-10%

Fatigue

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Headache

0.1-1%

Nausea

0.1-1%

TRAVOPROST OPHTHALMIC SOLUTION

Drug Not Working

1-10%

Fatigue

0.1-1%

Blurred Vision

0.1-1%

Dizziness

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

TIMOLOL MALEATE

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically
For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS )
, chronic bronchitis, emphysema) of mild or moderate severity, bronchospastic disease, or a history of bronchospastic disease (other than bronchial asthma or a history of bronchial asthma, in which Timolol Maleate Ophthalmic Solution in OCUDOSE is contraindicated [see CONTRAINDICATIONS ]) should, in general, not receive beta-blockers, including Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE
This may augment the risk of general anesthesia in surgical procedures

TRAVOPROST OPHTHALMIC SOLUTION

5 WARNINGS AND PRECAUTIONS • Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid), and eyelashes can occur
004% should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Clinical Trial Data

No head-to-head clinical studies found for TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION.

TIMOLOL MALEATE vs TRAVOPROST OPHTHALMIC SOLUTION: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.